Sentence: Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase .
Drug combination annotation:
[{'class': 'POS', 'spans': ['imatinib', 'cytarabine'], 'is_context_needed': True}]